Introduction
Methods
Results
Discussion
Limitations
Conclusion

INTRODUCTION

The decision of whether to triage an injured patient to a trauma center can be difficult, and most emergency medical system (EMS) agencies rely on standardized decision-making systems.¹ Traditional trauma triage systems rely heavily on vital sign abnormalities to identify patients in need of a trauma center. Shock index (SI) is one vital-sign marker that has been identified as an early predictor of severe injury.² However, multiple studies have demonstrated that vital signs are limited in this role.^1,3-8

Field measurement of serum lactate concentration could be of potential benefit in accurately identifying patients with more severe injury and need for resuscitative care (RC). Lactic acid is a byproduct of anaerobic metabolism and is a marker of inadequate tissue oxygenation or shock. Technological advancements have led to the development of rapid, portable, lactate assays, permitting lactate measurement in the prehospital and early clinical setting. Previous studies have demonstrated that elevated prehospital and emergency department (ED) lactate levels are predictive of poor outcomes in several populations: septic patients, cardiac arrest patients, and general medical patients.^9-15 Prehospital lactate has also been validated in two populations of patients selected for severe injury: those transported by helicopter and those with prehospital hypotension (systolic blood pressure ≤ 100 mmHg).^16-18

However, the prognostic utility of a prehospital lactate level has not been studied systematically in a population of normotensive trauma patients encountered by ground advanced life support (ALS) crews. Of particular interest is the question of whether the test can risk-stratify normotensive trauma patients and retain specificity for the need for RC when applied to a much broader population with a lower overall prevalence of severe injury than those previously studied. (Note: For the purposes of this paper, the term “normotensive” should be taken to mean any patient with systolic blood pressure > 100 mmHg.) We sought to determine the test characteristics of prehospital lactate levels for predicting need for resuscitative care among a broad population of normotensive trauma patients being transported by ground ALS units.

METHODS

This study was approved by the University of Washington Institutional Review Board. It was a retrospective analysis of a prospective cohort study of all trauma patients transported by ground ALS units of the Seattle Fire Department between June 24, 2011, and August 21, 2012. In this two-tiered EMS system, ALS treatment and transport to a trauma center is triggered by a significant mechanism of injury, Glasgow Coma Scale ≤ 12, vital-sign abnormalities, neurovascular deficits, and injury pattern, in keeping with Washington State Department of Health Prehospital Trauma Guidelines.¹⁹ Patients excluded from lactate measurement were those with age less than 15 years; obvious isolated, penetrating head trauma; drowning; asphyxia caused by hanging; burns greater than 20% body surface area; or known prisoner status. We also excluded patients with prehospital systolic blood pressure ≤ 100 mmHg because they had already been analyzed in a prior study with this population showing strong correlation between lactate and outcomes.¹⁷ This allowed our study to determine the lactate test characteristics among a population that might not be preferentially transported to a high-level trauma center.

Serum lactate levels were drawn upon placement of an intravenous line. A drop of blood was placed on a test strip, which was inserted into a handheld measurement device (Lactate Pro, Arkray Inc., Kyoto, Japan). The Lactate Pro meter is similar in size and operation to the glucometers used by our EMS agencies and has a run time of 60 seconds.²⁰ EMS and hospital providers recorded the test result in the patient’s chart but were instructed not to change care based on the number. Data were entered into a local database created specifically for study of prehospital lactate performance. All ALS patients in this catchment area were transported to a single Level I trauma center, Harborview Medical Center. Clinical variables from the time period after ED arrival through death or hospital discharge were obtained by review of electronic health records.

Population Health Research Capsule

What do we already know about this issue?

Prehospital triage decisions for trauma patients are based on vital signs, but this misses some injuries. Prehospital lactate measurement could improve this process.

What was the research question?

How predictive is prehospital lactate in predicting severe injury in normotensive trauma patients?

What was the major finding of the study?

Prehospital lactate was predictive of severe injury with reasonable sensitivity and specificity.

How does this improve population health?

This will help inform EMS medical directors of the potential benefits and risks of incorporating prehospital lactate measurement into their trauma triage protocols.

The primary clinical outcome of interest was need for RC. This was defined as death in the ED, disposition to operating room or interventional radiology within six hours, or transfusion of five units of any blood product within six hours of ED arrival. This outcome was used in the prior study of prehospital lactate in hypotensive trauma patients.¹⁷ It is used here both for consistency to facilitate comparison of results to the prior study and because we believe it accurately defines a population of injured patients that requires high-level trauma care.

In the primary analysis, we defined the normal distribution of prehospital lactate. Subsequently, we evaluated its ability to predict the need for RC and compared it to the same predictive ability of shock index (SI = heart rate [HR] / systolic blood pressure [SBP]) by calculating the area under the curve of the receiver operator characteristic (AUROC) for each. The AUROCs were compared using the DeLong-DeLong-Clarke-Pearson method.²¹ We also calculated the sensitivity and specificity of a prehospital lactate level of 2.5 mmol/L or greater. This cutoff has been previously validated in trauma populations and was chosen to maximize the generalizability of our results.^16,22 The optimal cutoff point for the study population was also calculated by selecting the point visually determined to most closely represent an inflection point in the ROC curve that minimized loss of sensitivity but maximized specificity.

In planned secondary analyses, the AUROCs were calculated and compared in the predefined subpopulations of blunt and penetrating injury patients. We also calculated the AUROCs for prehospital lactate and SI for predicting the alternative outcomes of moderate and severe injury, as defined by injury severity score (ISS) > 9 and 15, respectively. These cutoffs were chosen because they have been used historically to represent moderate and severe injury and have been validated to be useful surrogates for patients who will benefit from triage to a trauma center.^23-28

Finally, we did an exploratory analysis to further investigate the relationship between prehospital lactate and likelihood of need for RC. For this analysis, a multivariate logistic regression was performed that included need for RC as its outcome and a linear spline of lactate with knots at 2.5 and 4 mmol/L as the predictor of interest. We chose this model to allow for a possible non-linear relationship between lactate concentration and risk of need for RC. Cutpoints were previously validated in unrelated studies, indicating that they represent separation points of trauma patients with different outcomes.²⁹ We used Wald tests to determine significance.

RESULTS

We screened 371 patients for enrollment, and 314 were included in analysis. Of the 57 excluded patients, 50 were excluded for a missing prehospital lactate. The reason given for a missing lactate in those 50 patients was paramedic failure to run the test in 19 patients; ongoing cardiopulmonary resuscitation in 12 patients; unsecure scene in three patients; unstable vital signs in three patients; prolonged extrication in two patients; immediate adjacency to the trauma center in one patien;, and device malfunction in one patient. No reason was provided for eight patients. We also excluded seven patients who were missing a recorded initial HR or SBP necessary to calculate SI. Figure 1 summarizes inclusion/exclusion numbers. Demographic, injury, and hospital data for all included patients are summarized in the table.

The AUROC for prehospital lactate prediction of need for RC was 0.716 (95% confidence interval [CI] [0.632 – 0.800]) and for SI was 0.631 (95% CI [0.537 – 0.724]) (Figure 2). The AUROC for prehospital lactate did not differ from that for SI (p=0.125). Among normotensive patients, a prehospital lactate level of 2.5 mmol/L or greater had a sensitivity of 74.6% and specificity of 53.4% for predicting need for RC. Increasing the lactate cutoff level to 3.0, where there is an inflection point in the ROC curve, resulted in improvement in specificity (66.9%) with only modest change in sensitivity (70.9%). In this population, SI of 0.9 or greater (a commonly recognized marker for severe injury in trauma patients) had low sensitivity for predicting need for RC (30.8%) but high specificity (89.9%). Being positive for either prehospital lactate level of 2.5 mmol/L or greater or SI of 0.9 or greater had only slightly different sensitivity (77.6%) and specificity (49.8%) than with prehospital lactate prediction alone.

Looking at each of the individual outcomes defining need for RC, prehospital lactate had similar predictive power for each. The AUROC for predicting need for emergent surgery was 0.721 (95% CI [0.630 – 0.811]), for predicting transfusion of five units of blood products was 0.785 (95% CI [0.669 – 0.901]) and for predicting death in the ED was 0.863 (95% CI could not be calculated, because there was only one event).

Among the 260 blunt injury patients, the AUROC for prehospital lactate prediction of need for RC was 0.732 (95% CI [0.637 – 0.827]), which was not significantly different from that for SI at 0.657 (95% CI [0.545 – 0.769]) (p=0.121). Among the 54 penetrating injury patients, the AUROC for prehospital lactate was 0.636 (95% CI [0.473 – 0.798]) and for SI was 0.550 (95% CI [0.374 – 0.726]) (p=0.478). In predicting the secondary clinical outcome of moderate injury (ISS > 9), the AUROC for prehospital lactate was 0.592 (95% CI [0.528 – 0.655]) and for SI was 0.594 (95% CI [0.530 – 0.657]) (p=0.954). In predicting severe injury (ISS > 15), the AUROC for prehospital lactate was 0.648 (95% CI [0.580 – 0.716]) and for SI was 0.647 (95% CI [0.576 – 0.718]) (p=0.979).

In the exploratory analysis, the odds ratios for need for RC associated with a 1-mmol/L increase in prehospital lactate concentration was 1.29 (95% CI [0.40 – 4.12], p=0.666) for lactate levels less than 2.5 mmol/L, 2.27 (95% CI [1.10 – 4.68], p=0.027) for lactate levels between 2.5 and 4.0 mmol/L, and 1.26 (95% CI [1.05 – 1.50], p=0.011) for lactate levels greater than 4.0 mmol/L.

DISCUSSION

In this retrospective cross-sectional analysis of normotensive trauma patients who met criteria for ALS transport, prehospital lactate concentration as measured by a handheld, point-of-care (POC) assay was predictive of the need for RC. Lactate offered no significant performance benefit over shock index by AUROC. However, we propose that it has several advantages over SI. First, it is less prone to error and easier to calculate in real-time during a patient transport. Second, a PLac cutoff of 3.0 offered superior sensitivity (70.9%) over the commonly used SI cutoff of 0.9 (30.8%). Though this came at a modest cost in specificity (66.9 vs. 89.9%), the emphasis for a screening tool in this population is to avoid false-negatives. Third, because prehospital lactate has been demonstrated to be a useful adjunct in the triage of hypotensive ALS transports, its use in normotensive ALS transports could simplify protocols to include a prehospital lactate for any ALS transport. These advantages should be weighed against the disadvantages of cost of equipment and assay, requirement for training, additional time to run the assay, and potential distraction from directly caring for the patient.

The POC meter used in this study cost approximately $300 and required about $2 per use as a disposable cartridge. Our results are similar to those previously seen in hypotensive trauma patients, though each test (prehospital lactate and SI) had slightly lower AUROCs in this non-hypotensive population, likely owing to the rarer need for RC. This is the first prehospital study to examine the ability of prehospital lactate to risk-stratify normotensive trauma patients.

The lactate cutoff of 2.5 mmol/L that has been validated in other trauma populations had a high sensitivity at 75% and maintained specificity at 53%. This indicates that the test may have future value in decreasing undertriage without paying a heavy price in overtriage. One of the critical questions in extending the application of this test to a lower-acuity trauma population than previously studied is whether there would be a major decrease in specificity. Raising the cutoff level to 3.0 mmol/L led to a large increase in specificity with only a small cost paid in sensitivity in this population. However, it is important to note that the same is likely not true in the larger population that includes hypotensive patients. Prospective testing would be needed in the target population with specific comparison of a triage protocol incorporating the prehospital lactate to current triage guidelines.

In the subpopulation secondary analyses, prehospital lactate maintained a high AUROC for both blunt and penetrating patients. Prehospital lactate had no significant difference in performance compared to SI in the blunt or penetrating injury population, though there was a p-value of 0.121 trending toward superior performance in blunt injury. It is difficult to interpret these results in light of the smaller subgroup sample sizes and unknown power due to the lack of prior data in this population, particularly in the penetrating injury group. However, given that most triage criteria direct all penetrating injuries proximal to the knee or elbow to trauma centers already, the test performance comparison in this group might be less relevant.

When examining the prediction of the secondary clinical outcomes of moderate and severe injury (ISS > 9 and 15), prehospital lactate had markedly worse performance. The reasons for this are unclear but could include the fact that hypotensive patients were excluded, making a high ISS more likely representative of extremity and facial injuries less likely to cause shock and limiting the utility of lactate measurement. However, ultimately the high ISS outcome has been used in prior studies as a surrogate measurement predictive of need for RC; in our study, the lactate concentration was directly measured against clinical need for RC, making the primary analysis more impactful than this one.

The exploratory analysis showed that increases in prehospital lactate were associated with increased risk of need for RC only above lactate levels of 2.5 mmol/L. It also showed there is more risk associated with a 1-mmol/L increase in lactate concentration in the range of 2.5 to 4.0 mmol/L, and the increase in risk decreases in the higher lactate ranges. This is both logical, given the relatively high baseline risk associated with any lactate > 4.0, and in keeping with prior findings in a hypotensive trauma population.¹⁷

In conjunction with previous studies on prehospital lactate in trauma patients, these findings suggest that prehospital lactate could improve overall triage for ALS patients, and we suggest that it should be investigated prospectively as a rapid test in the field to identify occult shock. Among patients meeting local criteria for ALS transport, future investigation should test the integration of prehospital lactate into existing field triage decision rules to determine accuracy in the decision to transport to a trauma center. To account for the possible lack of improvement provided by prehospital lactate testing in the normotensive ALS transport population, future trials should include a planned subgroup analysis of normotensive patients. If found to be beneficial, testing could also be investigated for use by basic life support (BLS) providers to identify patients with occult shock requiring ALS transport, given that the tasks required for testing are within the BLS skillset. The role of the test should be further investigated primarily to prevent undertriage, as its test characteristics show that this would likely come at a relatively low cost of overtriage, even among normotensive trauma patients. A positive result could also hold promise for triggering more aggressive field treatment, including the earlier use of prehospital blood products in EMS systems with the capability to do so, though this would also require further study.

LIMITATIONS

This study has several limitations. First, although the data were collected prospectively, this is a retrospective analysis, which limits some of the granularity of the data. Second, because we lacked the ability to determine specific operative procedures being performed, we used disposition to OR within six hours as a surrogate for surgical hemorrhage control. This would inadvertently include the uncommon patient undergoing a non-emergent surgical procedure within six hours of ED arrival, such as open reduction internal fixation, but that would only bias the results towards a worse sensitivity for prehospital lactate. Third, the definitions for the composite outcome of need for RC were chosen subjectively. They were chosen both for ease of comparison to prior literature and because the authors felt they accurately represented a population requiring higher-level trauma care, but it could be argued that this is not an optimally targeted population.

Fourth, this study still only included patients meeting ALS criteria in a two-tiered system. It is important to note that, although this population includes normotensive trauma patients, the findings could not be extended to the population transported by BLS in our system. Furthermore, the impact of inclusion of prehospital lactate into any triage protocol would need to be investigated prospectively before it could be recommended for implementation. Fifth, while the lactate meter used in the study is Clinical Laboratory Improvement Amendment-waived, it is no longer commercially available. The Lactate Pro is operated identically to the POC glucose meter used on ambulances with minimal operational error. The devices are robust and reliable with a low failure rate.²⁰ During the study period, the meter did not require calibration. Future lactate meters available for prehospital use may be more complicated both in their operation and their administrative overhead.

Finally, we did not have access to all prehospital data, so we were unable to compare the performance of the current triage algorithm to what the performance would have been with a triage algorithm incorporating the prehospital lactate data. This study also has several important strengths, including prospective collection of the data and the single receiving center for patients, enhancing the collection of detailed in-hospital data.

CONCLUSION

In conclusion, this study suggests that prehospital lactate could be useful in risk-stratifying normotensive trauma patients. Prospective validation of existing triage decision rules augmented by prehospital lactate should be a focus of future investigation.

Footnotes

Section Editor: David Peak, MD

Full text available through open access at http://escholarship.org/uc/uciem_westjem

Address for Correspondence: Alexander St. John, MD, MS, Box 359702, 325 9^th Ave., Seattle, WA 98104. Email: aestjohn@uw.edu. 3 / 2018; 19:224 – 231

Submission history: Revision received April 22, 2017; Submitted September 27, 2017; Accepted October 6, 2017

Conflicts of Interest: By the WestJEM article submission agreement, all authors are required to disclose all affiliations, funding sources and financial or management relationships that could be perceived as potential sources of bias. No author has professional or financial relationships with any companies that are relevant to this study. There are no conflicts of interest or sources of funding to declare.

REFERENCES

1. Sasser SM, Hunt RC, Faul M, et al. Guidelines for field triage of injured patients: recommendations of the National Expert Panel on Field Triage, 2011. MMWR Recomm Rep. 2012;61(Rr-1):1-20.

2. King RW, Plewa MC, Buderer NM, et al. Shock index as a marker for significant injury in trauma patients. Acad Emerg Med. 1996;3(11):1041-5.

3. McGee S, Abernethy WB, Simel DL. The rational clinical examination. Is this patient hypovolemic?. JAMA. 1999;281(11):1022-9.

4. Brasel KJ, Guse C, Gentilello LM, et al. Heart rate: is it truly a vital sign?. J Trauma. 2007;62(4):812-7.

5. Newgard CD, Rudser K, Hedges JR, et al. A critical assessment of the out-of-hospital trauma triage guidelines for physiologic abnormality. J Trauma. 2010;68(2):452-62.

6. Lipsky AM, Gausche-Hill M, Henneman PL, et al. Prehospital hypotension is a predictor of the need for an emergent, therapeutic operation in trauma patients with normal systolic blood pressure in the emergency department. J Trauma. 2006;61(5):1228-33.

7. Eastridge BJ, Salinas J, McManus JG, et al. Hypotension begins at 110 mm Hg: redefining “hypotension” with data. J Trauma. 2007;63(2):291-7.

8. Henry MC, Hollander JE, Alicandro JM, et al. Incremental benefit of individual American College of Surgeons trauma triage criteria. Acad Emerg Med. 1996;3(11):992-1000.

9. Prause G, Ratzenhofer-Comenda B, Smolle-Juttner F, et al. Comparison of lactate or BE during out-of-hospital cardiac arrest to determine metabolic acidosis. Resuscitation. 2001;51(3):297-300.

10. Jansen TC, van Bommel J, Mulder PG, et al. The prognostic value of blood lactate levels relative to that of vital signs in the pre-hospital setting: a pilot study. Crit Care. 2008;12(6):R160.

11. Vandromme MJ, Griffin RL, Weinberg JA, et al. Lactate is a better predictor than systolic blood pressure for determining blood requirement and mortality: could prehospital measures improve trauma triage?. J Am Coll Surg. 2010;210(5):861-7.

12. Guerra WF, Mayfield TR, Meyers MS, et al. Early detection and treatment of patients with severe sepsis by prehospital personnel. J Emerg Med. 2013;44(6):1116-25.

13. van Beest PA, Mulder PJ, Oetomo SB, et al. Measurement of lactate in a prehospital setting is related to outcome. Eur J Emerg Med. 2009;16(6):318-22.

14. Tobias AZ, Guyette FX, Seymour CW, et al. Pre-resuscitation lactate and hospital mortality in prehospital patients. Prehosp Emerg Care. 2014;18(3):321-7.

15. Mullen M, Cerri G, Murray R, et al. Use of point-of-care lactate in the prehospital aeromedical environment. Prehosp Disaster Med. 2014;29(2):200-3.

16. Guyette F, Suffoletto B, Castillo JL, et al. Prehospital serum lactate as a predictor of outcomes in trauma patients: a retrospective observational study. J Trauma. 2011;70(4):782-6.

17. Guyette FX, Meier EN, Newgard C, et al. A comparison of prehospital lactate and systolic blood pressure for predicting the need for resuscitative care in trauma transported by ground. J Trauma Acute Care Surg. 2015;78(3):600-6.

18. Shah A, Guyette F, Suffoletto B, et al. Diagnostic accuracy of a single point-of-care prehospital serum lactate for predicting outcomes in pediatric trauma patients. Pediatr Emerg Care. 2013;29(6):715-9.

19. State of Washington Prehospital Trauma Triage (Destination) Procedure. 2012. Available at: www.doh.wa.gov/portals/1/documents/pubs/530143.pdf.

20. Bonaventura JM, Sharpe K, Knight E, et al. Reliability and accuracy of six hand-held blood lactate analysers. J Sports Sci Med. 2015;14(1):203-14.

21. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-45.

22. Odom SR, Howell MD, Silva GS, et al. Lactate clearance as a predictor of mortality in trauma patients. J Trauma Acute Care Surg. 2013;74(4):999-1004.

23. Resources for Optimal Care of the Injured Patient – Sixth Edition. 2014.

24. MacKenzie EJ, Rivara FP, Jurkovich GJ, et al. A national evaluation of the effect of trauma-center care on mortality. N Engl J Med. 2006;354(4):366-78.

25. Mullins RJ, Veum-Stone J, Hedges JR, et al. Influence of a statewide trauma system on location of hospitalization and outcome of injured patients. J Trauma. 1996;40(4):536-45.

26. Mullins RJ, Mann NC. Population-based research assessing the effectiveness of trauma systems. J Trauma. 1999;47(3 Suppl):S59-66.

27. Jurkovich GJ, Mock C. Systematic review of trauma system effectiveness based on registry comparisons. J Trauma. 1999;47(3 Suppl):S46-55.

28. Hulka F, Mullins RJ, Mann NC, et al. Influence of a statewide trauma system on pediatric hospitalization and outcome. J Trauma. 1997;42(3):514-9.

29. Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524-8.

Share on Facebook

Tweet

Share via email